Paxman to showcase FDA approved scalp cooler for chemotherapy induced alopecia at ASC

[News]

A pioneering scalp cooling treatment that prevents alopecia in breast cancer patients undergoing chemotherapy will be showcased at the American Society of Clinical Oncology (ASCO) for the first time since gaining FDA clearance.

More... (http://www.news-medical.net/news/20170519/Paxman-to-showcase-FDA-approved-scalp-cooler-for-chemotherapy-induced-alopecia-at-ASCO.aspx)